Shionogi & Co., Ltd. (SGIOF)
PNK · Healthcare · Drug Manufacturers - Specialty & Generic
Closing price as of 2026-07-28 · Source: TEK2day Finance
Key Metrics
About Shionogi & Co., Ltd.
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
Quarterly Financials
| Metric | 2025-06-30 |
|---|---|
| Diluted EPS | $46.25 |
Annual Financials
| Metric | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 426.7B | 435.1B | 438.3B | 499.7B |
| Gross Profit | 364.4B | 377.5B | 374.4B | 417.2B |
| Operating Income | 149.0B | 153.3B | 156.6B | 166.7B |
| Net Income | 185.0B | 162.0B | 170.4B | 205.2B |
| Diluted EPS | $207.03 | $186.11 | $200.29 | $241.04 |